This Biotech with Breakout MS Drug Draws Big Investment
A breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Cash back taxes can be confusing. This guide provides essential insights to help you navigate your tax responsibilities.
22,480 articlesA breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Himax (HIMX) faces a pivotal year as AR/VR, automotive displays, and smartphone drivers shape demand. This Q1 2026 ea...
Investors weigh a fresh entry point for ServiceNow as the stock resets after sector-wide multiple compression. Analys...
SpaceX lit up the market with a big debut, yet the price tag raised serious questions. This article breaks down why m...
Investors are asking if one AI leader can justify a multibillion-dollar market cap shift. This guide breaks down what...
When penguin stock popped today, investors asked: what changed in a single session? This article breaks down the cata...
Taiwan Semiconductor is in the spotlight as it signals higher capital spending. This article breaks down whether tsmc...
ImmunityBio has grabbed headlines as shares surge amid regulatory wins and pipeline potential. This deep dive explain...
March trading action kept pushing higher as Plug Power surged again, helping to lead a broader market rally. This art...
As markets swing in 2026, two famous retirement voices clash on the best time to claim Social Security. Their debate ...
When Oshkosh released its latest results, the focus quickly shifted to a sharp stock move. This guide explains what h...
As AI reshapes enterprise tech, investors wonder if CrowdStrike can translate vigilance into lasting outsized returns...